Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Indices of dentate gyrus neurogenesis are unaffected immediately after or following withdrawal from morphine self-administration compared to saline self-administering control male rats.

Bulin SE, Simmons SJ, Richardson DR, Latchney SE, Deutsch HM, Yun S, Eisch AJ.

Behav Brain Res. 2020 Mar 2;381:112448. doi: 10.1016/j.bbr.2019.112448. Epub 2019 Dec 20.

PMID:
31870778
2.

Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect.

Simmons SJ, Gentile TA.

Brain Res. 2019 Feb 20:146164. doi: 10.1016/j.brainres.2019.02.026. [Epub ahead of print]

PMID:
30796894
3.

Image-guided cranial irradiation-induced ablation of dentate gyrus neurogenesis impairs extinction of recent morphine reward memories.

Rivera PD, Simmons SJ, Reynolds RP, Just AL, Birnbaum SG, Eisch AJ.

Hippocampus. 2019 Aug;29(8):726-735. doi: 10.1002/hipo.23071. Epub 2019 Feb 18.

PMID:
30779299
4.

Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.

Gentile TA, Simmons SJ, Tallarida CS, Su S, Rom S, Watson MN, Reitz AB, Potula R, Rawls SM.

Drug Alcohol Depend. 2019 Apr 1;197:22-27. doi: 10.1016/j.drugalcdep.2018.12.022. Epub 2019 Jan 31.

PMID:
30754021
5.

Synthetic cathinone adulteration of illegal drugs.

Oliver CF, Palamar JJ, Salomone A, Simmons SJ, Philogene-Khalid HL, Stokes-McCloskey N, Rawls SM.

Psychopharmacology (Berl). 2019 Mar;236(3):869-879. doi: 10.1007/s00213-018-5066-6. Epub 2018 Oct 18. Review.

PMID:
30338489
6.

DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.

Simmons SJ, Leyrer-Jackson JM, Oliver CF, Hicks C, Muschamp JW, Rawls SM, Olive MF.

ACS Chem Neurosci. 2018 Oct 17;9(10):2379-2394. doi: 10.1021/acschemneuro.8b00147. Epub 2018 May 11. Review.

7.

Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.

Oliver CF, Simmons SJ, Nayak SU, Smith GR, Reitz AB, Rawls SM.

Drug Alcohol Depend. 2018 May 1;186:75-79. doi: 10.1016/j.drugalcdep.2018.01.013. Epub 2018 Mar 10.

8.

Loci That Control Nonlinear, Interdependent Responses to Combinations of Drought and Nitrogen Limitation.

Chang MM, Nail DA, Kazic T, Simmons SJ, Stapleton AE.

G3 (Bethesda). 2018 May 4;8(5):1481-1496. doi: 10.1534/g3.118.200123.

9.

Stereoselective Differences between the Reinforcing and Motivational Effects of Cathinone-Derived 4-Methylmethcathinone (Mephedrone) In Self-Administering Rats.

Philogene-Khalid HL, Simmons SJ, Nayak S, Martorana RM, Su SH, Caro Y, Ranieri B, DiFurio K, Mo L, Gentile TA, Murad A, Reitz AB, Muschamp JW, Rawls SM.

ACS Chem Neurosci. 2017 Dec 20;8(12):2648-2654. doi: 10.1021/acschemneuro.7b00212. Epub 2017 Sep 22.

10.

Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.

Simmons SJ, Martorana R, Philogene-Khalid H, Tran FH, Gentile TA, Xu X, Su S, Rawls SM, Muschamp JW.

Psychopharmacology (Berl). 2017 Nov;234(21):3207-3215. doi: 10.1007/s00213-017-4709-3. Epub 2017 Aug 7.

11.

Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine.

Gentile TA, Simmons SJ, Watson MN, Connelly KL, Brailoiu E, Zhang Y, Muschamp JW.

Neuropsychopharmacology. 2018 Apr;43(5):1001-1009. doi: 10.1038/npp.2017.158. Epub 2017 Jul 25.

12.

Effects of ceftriaxone on conditioned nicotine reward in rats.

Philogene-Khalid HL, Simmons SJ, Muschamp JW, Rawls SM.

Behav Pharmacol. 2017 Sep;28(6):485-488. doi: 10.1097/FBP.0000000000000314.

13.

Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine.

Gentile TA, Simmons SJ, Barker DJ, Shaw JK, España RA, Muschamp JW.

Addict Biol. 2018 Jan;23(1):247-255. doi: 10.1111/adb.12507. Epub 2017 Apr 17.

14.

Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.

Simmons SJ, Gregg RA, Tran FH, Mo L, von Weltin E, Barker DJ, Gentile TA, Watterson LR, Rawls SM, Muschamp JW.

Addict Biol. 2018 Jan;23(1):102-110. doi: 10.1111/adb.12479. Epub 2016 Dec 1.

15.

Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats.

Simmons SJ, Gentile TA, Mo L, Tran FH, Ma S, Muschamp JW.

Behav Brain Res. 2016 Nov 1;314:226-33. doi: 10.1016/j.bbr.2016.07.053. Epub 2016 Aug 1.

16.
17.

Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models.

Fang Q, Piegorsch WW, Simmons SJ, Li X, Chen C, Wang Y.

Biometrics. 2015 Dec;71(4):1168-75. doi: 10.1111/biom.12340. Epub 2015 Jun 23.

PMID:
26102570
18.

Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.

Simmons SJ, Gould TJ.

J Clin Pharm Ther. 2014 Oct;39(5):457-67. doi: 10.1111/jcpt.12171. Epub 2014 May 14. Review.

19.

Nicotine shifts the temporal activation of hippocampal protein kinase A and extracellular signal-regulated kinase 1/2 to enhance long-term, but not short-term, hippocampus-dependent memory.

Gould TJ, Wilkinson DS, Yildirim E, Poole RL, Leach PT, Simmons SJ.

Neurobiol Learn Mem. 2014 Mar;109:151-9. doi: 10.1016/j.nlm.2014.01.009. Epub 2014 Jan 21.

20.

Abiotic stress growth conditions induce different responses in kernel iron concentration across genotypically distinct maize inbred varieties.

Kandianis CB, Michenfelder AS, Simmons SJ, Grusak MA, Stapleton AE.

Front Plant Sci. 2013 Dec 4;4:488. doi: 10.3389/fpls.2013.00488. eCollection 2013.

21.

Ultrasonic vocalizations: evidence for an affective opponent process during cocaine self-administration.

Barker DJ, Simmons SJ, Servilio LC, Bercovicz D, Ma S, Root DH, Pawlak AP, West MO.

Psychopharmacology (Berl). 2014 Mar;231(5):909-18. doi: 10.1007/s00213-013-3309-0. Epub 2013 Nov 7.

22.

Rat ultrasonic vocalizations demonstrate that the motivation to contextually reinstate cocaine-seeking behavior does not necessarily involve a hedonic response.

Barker DJ, Bercovicz D, Servilio LC, Simmons SJ, Ma S, Root DH, Pawlak AP, West MO.

Addict Biol. 2014 Sep;19(5):781-90. doi: 10.1111/adb.12044. Epub 2013 Mar 18.

23.

A mutual acculturation model of multicultural campus climate and acceptance of diversity.

Simmons SJ, Wittig MA, Grant SK.

Cultur Divers Ethnic Minor Psychol. 2010 Oct;16(4):468-75. doi: 10.1037/a0020237.

24.
25.

Chromosomal loci important for cotyledon opening under UV-B in Arabidopsis thaliana.

Conte M, de Simone S, Simmons SJ, Ballaré CL, Stapleton AE.

BMC Plant Biol. 2010 Jun 16;10:112. doi: 10.1186/1471-2229-10-112.

26.

Maize leaf epiphytic bacteria diversity patterns are genetically correlated with resistance to fungal pathogen infection.

Balint-Kurti P, Simmons SJ, Blum JE, Ballaré CL, Stapleton AE.

Mol Plant Microbe Interact. 2010 Apr;23(4):473-84. doi: 10.1094/MPMI-23-4-0473.

28.
29.

President's message: what defines effective health care?

Simmons SJ.

Pa Nurse. 2005 Dec;60(5):3. No abstract available.

PMID:
16512496
30.

Message from the president: a personal encounter with healthy work environments.

Simmons SJ.

Pa Nurse. 2005 Sep;60(4):2. No abstract available.

PMID:
16295988
31.

Nursing's role in health care reform.

Simmons SJ.

Pa Nurse. 2005 Jun;60(3):2. No abstract available.

PMID:
16032976
32.

Professional advocacy: to inform, involve and inspire.

Simmons SJ.

Pa Nurse. 2005 Mar;60(2):3. No abstract available.

PMID:
15909618
33.

Message from the president: A new year for caring.

Simmons SJ.

Pa Nurse. 2005 Jan-Feb;60(1):2. No abstract available.

PMID:
15727118
34.

Presidential address. "Trilogy of Learning" - the 22nd Biennial Conference of the New Zealand Dental Association.

Simmons SJ.

N Z Dent J. 2004 Dec;100(4):99-100. No abstract available.

PMID:
15656431
35.

The Pennsylvania Health Care Cost Containment Council: a nursing perspective.

Simmons SJ.

Pa Nurse. 2004 Jan-Feb;59(1):5. No abstract available.

PMID:
15032084
36.

Statistical modeling and analyses of a base-specific Salmonella mutagenicity assay.

Piegorsch WW, Simmons SJ, Margolin BH, Zeiger E, Gidrol XM, Gee P.

Mutat Res. 2000 Apr 13;467(1):11-9.

PMID:
10771267
37.

Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients.

Murphy GP, Tjoa BA, Simmons SJ, Rogers MK, Kenny GM, Jarisch J.

Prostate. 2000 Apr 1;43(1):59-62.

PMID:
10725866
38.

Prostate-specific membrane antigen (PSMA): current benefits and future value.

Elgamal AA, Holmes EH, Su SL, Tino WT, Simmons SJ, Peterson M, Greene TG, Boynton AL, Murphy GP.

Semin Surg Oncol. 2000 Jan-Feb;18(1):10-6. Review.

PMID:
10617892
39.

Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients.

Murphy GP, Snow P, Simmons SJ, Tjoa BA, Rogers MK, Brandt J, Healy CG, Bolton WE, Rodbold D.

Prostate. 2000 Jan;42(1):67-72.

PMID:
10579800
40.

Follow-up evaluation of a phase II prostate cancer vaccine trial.

Tjoa BA, Simmons SJ, Elgamal A, Rogers M, Ragde H, Kenny GM, Troychak MJ, Boynton AL, Murphy GP.

Prostate. 1999 Jul 1;40(2):125-9.

PMID:
10386473
41.

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial.

Simmons SJ, Tjoa BA, Rogers M, Elgamal A, Kenny GM, Ragde H, Troychak MJ, Boynton AL, Murphy GP.

Prostate. 1999 Jun 1;39(4):291-7.

PMID:
10344219
42.

Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment.

Murphy GP, Tjoa BA, Simmons SJ, Ragde H, Rogers M, Elgamal A, Kenny GM, Troychak MJ, Salgaller ML, Boynton AL.

Prostate. 1999 Apr 1;39(1):54-9.

PMID:
10221267
43.

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease.

Murphy GP, Tjoa BA, Simmons SJ, Jarisch J, Bowes VA, Ragde H, Rogers M, Elgamal A, Kenny GM, Cobb OE, Ireton RC, Troychak MJ, Salgaller ML, Boynton AL.

Prostate. 1999 Jan 1;38(1):73-8.

PMID:
9973112
44.

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides.

Tjoa BA, Simmons SJ, Bowes VA, Ragde H, Rogers M, Elgamal A, Kenny GM, Cobb OE, Ireton RC, Troychak MJ, Salgaller ML, Boynton AL, Murphy GP.

Prostate. 1998 Jun 15;36(1):39-44.

PMID:
9650914
45.

The complete set of predicted genes from Saccharomyces cerevisiae in a readily usable form.

Hudson JR Jr, Dawson EP, Rushing KL, Jackson CH, Lockshon D, Conover D, Lanciault C, Harris JR, Simmons SJ, Rothstein R, Fields S.

Genome Res. 1997 Dec;7(12):1169-73.

46.
47.

Variant cDNA sequences of human ATP:citrate lyase: cloning, expression, and purification from baculovirus-infected insect cells.

Lord KA, Wang XM, Simmons SJ, Bruckner RC, Loscig J, O'Connor B, Bentley R, Smallwood A, Chadwick CC, Stevis PE, Ciccarelli RB.

Protein Expr Purif. 1997 Feb;9(1):133-41.

PMID:
9116495
48.

Production of active human interleukin-1 beta-converting enzyme in a baculovirus expression system.

Wang XM, Helaszek CT, Winter LA, Lirette RP, Dixon DC, Ciccarelli RB, Kelley MM, Malinowski JJ, Simmons SJ, Huston EE, et al.

Gene. 1994 Aug 5;145(2):273-7.

PMID:
8056342
49.

The economics of prevention.

Simmons SJ.

ANA Publ. 1993 Nov;(CH-27 5M):1-9. No abstract available.

PMID:
7810849
50.

Explaining health-promoting lifestyles of Navy personnel.

Simmons SJ.

Mil Med. 1993 Sep;158(9):594-8.

PMID:
8232996

Supplemental Content

Loading ...
Support Center